News tagged with asthma drugs
Scientists discover molecule that does double duty in stopping asthma attacks
Scientists from Brigham and Women's Hospital are on the brink of the next treatment advancement that may spell relief for the nearly nineteen million adults and seven million children in the United States ...
Inflammatory disorders
Feb 27, 2013 |
5 / 5 (3) |
0
|
Children taking steroids for asthma are slightly shorter than peers
Children who use inhaled steroid drugs for asthma end up slightly shorter at their full adult height than children who don't use the drugs, new results from a comprehensive asthma study show.
Immunology
Sep 03, 2012 |
5 / 5 (1) |
1
|
No link found between asthma drugs, suicide attempts
(Medical Xpress) -- Treating asthma with leukotriene-modifying agents does not pose an increased risk of suicide in children, according to new research at the University of Illinois at Chicago College of Pharmacy.
Immunology
Jul 04, 2012 |
not rated yet |
0
|
Heavy kids may not respond as well to asthma meds
(HealthDay) -- Overweight children may not respond as well to common asthma medicines known as inhaled corticosteroids, new research finds.
Inflammatory disorders
Mar 04, 2012 |
not rated yet |
0
|
Asthma treatment may be headed toward personalized medicine
Asthma patients could clearly benefit from personalized medicine, a new study suggests. However, the new discovery of a key gene, while exciting, does not mean that day is here quite yet.
Diseases, Conditions, Syndromes
Oct 05, 2011 |
not rated yet |
1
|
Antibiotics often the wrong prescription for pediatric asthma
(Medical Xpress) -- At nearly one in six pediatric asthma visits, antibiotics are prescribed as a remedy, despite national guidelines against the practice. Ian Paul, departments of pediatrics and public health sciences, Penn ...
Diseases, Conditions, Syndromes
Jun 01, 2011 |
not rated yet |
0
|
FDA approves once-a-day inhaler from Glaxo
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.
Medications
May 10, 2013 |
not rated yet |
0
Nearly 5 million asthmatics could benefit from antifungal therapy
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.
Inflammatory disorders
May 08, 2013 |
not rated yet |
0
Oral drops can give kids needle-free relief from asthma, allergies
Allergy shots are commonly used to treat children with severe environmental allergies and asthma, but under-the-tongue drops may offer yet another beneficial—and stick-free—option for pediatric allergy sufferers, according ...
Immunology
May 06, 2013 |
not rated yet |
0
US panel backs inhaler drug for lung disease
A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.
Medications
Apr 17, 2013 |
not rated yet |
0
Studies for approval of new drugs have insufficient patients to evaluate safety
For medicines intended for chronic use, the number of patients studied before regulatory approval is insufficient to properly evaluate safety and long-term efficacy, requiring the need for new legislation, according to a ...
Medications
Mar 19, 2013 |
not rated yet |
0
1990s trial gave early danger signs for asthma drugs
The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.
Medications
Nov 25, 2012 |
not rated yet |
0
Healthcare professionals as bad as patients at good respiratory inhaler technique
Healthcare professionals are as bad as patients when it comes to knowing how to use inhalers prescribed for asthma and other respiratory conditions correctly, says an editorial in Drug and Therapeutics Bulletin (DTB).
Diseases, Conditions, Syndromes
Oct 03, 2012 |
not rated yet |
0
Stopping controversial asthma drugs could have downside: study
(HealthDay)—It's OK for some patients with asthma to stick with a combination of medications instead of abandoning one because of concerns about complications, a new analysis of existing research suggests.
Immunology
Aug 27, 2012 |
not rated yet |
0
First generic versions of singulair approved
(HealthDay) -- The first generic versions of Singulair (montelukast sodium) have been approved by the U.S. Food and Drug Administration.
Medications
Aug 04, 2012 |
not rated yet |
0
